Antisense Therapeutics Limited (AU:PER)
ASX:PER
Holding AU:PER?
Track your performance easily

Antisense Therapeutics Limited (PER) Stock News & Sentiment

6 Followers
Percheron Therapeutics Unveils Corporate Update
Premium
Company Announcements
Percheron Therapeutics Unveils Corporate Update
16d ago
Percheron’s Avicursen Shows Hope for Epilepsy
Premium
Company Announcements
Percheron’s Avicursen Shows Hope for Epilepsy
17d ago
Percheron Therapeutics Maintains Full Governance Compliance
Premium
Company Announcements
Percheron Therapeutics Maintains Full Governance Compliance
22d ago
Percheron Therapeutics Reports Increased Annual Loss
Premium
Company Announcements
Percheron Therapeutics Reports Increased Annual Loss
22d ago
Percheron Therapeutics Advances DMD Drug Development
Premium
Company Announcements
Percheron Therapeutics Advances DMD Drug Development
2M ago
Percheron Therapeutics Options Issue Unveiled
Premium
Company Announcements
Percheron Therapeutics Options Issue Unveiled
3M ago
Percheron Therapeutics Welcomes New CFO
Premium
Company Announcements
Percheron Therapeutics Welcomes New CFO
3M ago
More ATHJF News >

News Score - Last 7 Days

Neutral
AU:PER
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:PER’s Media Buzz Sentiment?
1 articles about AU:PER were published this week. In an average week, 1.75 articles are published.
    What is AU:PER’s weekly average amount of articles?
    In an average week, 1.75 articles about AU:PER are published.
      What is AU:PER’s News Sentiment?
      50% of articles about AU:PER were positive this week, compared to its sector average of 60%.
        Healthcare Stocks that are Trending in the News
        NUVLNuvalent
        BLCOBausch + Lomb Corporation
        INCYIncyte
        ACRVAcrivon Therapeutics, Inc.
        EWTXEdgewise Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis